EQUEST ORAL GEL, 18,92 MG/G, ORAL GEL FOR HORSES AND PONIES
EQUEST ORAL GEL, 18,92 MG/G, ORAL GEL FOR HORSES AND PONIES
Authorised
- Moxidectin
Product identification
Medicine name:
EQUEST ORAL GEL, 18,92 MG/G, ORAL GEL FOR HORSES AND PONIES
Active substance:
- Moxidectin
Target species:
-
Horse
-
Horse (pony)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Moxidectin18.92/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Oral gel
Withdrawal period by route of administration:
-
Oral use
-
Horse
-
Meat and offal32day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Available in:
-
Netherlands
Package description:
- Box containing one syringe containing 14,8 g of gel
- Box containing 20 syringes containing 14,8 g of gel
- Box containing 10 individually boxed syringes containing 14,8 g of gel
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 9548
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0020/002
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Finland
-
Germany
-
Ireland
-
Italy
-
Luxembourg
-
Netherlands
-
Portugal
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 28/08/2024